跳至主要内容
临床试验/JPRN-UMIN000048886
JPRN-UMIN000048886已完成Unknown

Examination of lipid metabolism-improving effects by taking a single dose of test beverage - Examination of lipid metabolism-improving effects by taking a single dose of test beverage

CPCC Company Limited0 个研究点目标入组 40 人开始时间: 2023年9月12日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects taking steadily (not less than 3 times a week) in the following affecting foods; health-specific, functional, health foods (related to blood pressure, blood stream, exercise fatigue, metabolism-improving, poor blood flow-improving, fat combustion and/or lipolysis), supplementary one, vitamin tablet and nutrient, with any difficulty in refraining from having those after the consent. (2) Subjects who have any difficulty in refraining from taking steadily (not less than 3 times a week) in affecting medicines (e.g., lipid metabolism), during this trial. (3) Subjects with any possibility of hindrance to this trial, owing to their allergic rhinitis. (4) Subjects with not less than 25.0 kg/m2 of BMI and not less than 100 cm2 of abdominal fat area, at the consent. (5) Subjects who take excessive alcohol. (6) Subjects having a habit of smoking. (7) Subjects who are now under other clinical tests, or partook in those within 4 weeks before this trial. (8) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. (9) Pregnant, possibly pregnant, or lactating women. (10) Subjects suffering from severe anemia. (11) Subjects having drug and/or food allergy. (12) Subjects who donated over 0.2 L of their whole blood and/or blood components within a month before this trial. (13) Males who donated their whole blood (0.4 L) within the last 3 months to this trial. (14) Females who donated their whole blood (0.4 L) within the last 4 months to this trial. (15) Males who will be collected in total of their blood (1.2 L) within the last 12 months, after adding the blood amounts planning to be sampled in this trial. (16) Females who will be collected in total of their blood (0.8 L) within the last 12 months, after adding the blood amounts planning to be sampled in this trial. (17) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

研究者

发起方
CPCC Company Limited

相似试验